REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Nulab Pharmaceutical Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Nulab Pharmaceutical Indonesia Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

PT Nulab Pharmaceutical Indonesia is based in Indonesia, with the head office in West Jakarta. It operates in the Pharmaceutical Preparation Manufacturing industry. PT Nulab Pharmaceutical Indonesia was incorporated on October 17, 2008. 300 (estimated) employees currently work for PT Nulab Pharmaceutical Indonesia. The company’s latest financial report indicates a net sales revenue increase of 11.36% in 2024. Its total assets grew by 14.03% over the same period.

Headquarters
Komplek Green Ville Maisonette Blok FB No. 5-6
West Jakarta; Jakarta; Postal Code: 11510

Contact Details: Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.

Website: http://www.nulabpharmaceutical.com

Basic Information
Total Employees:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Registered Capital:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Financial Auditors:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Incorporation Date:
October 17, 2008
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Nulab Pharmaceutical Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
11.36%
Total Operating Revenue
11.36%
Total Assets
14.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?